Human ACAT1 gene expression and its involvement in the development of atherosclerosis

Future Cardiology

Volumn 2, Issue 1, 2006, Pages 93-99

  Li, Bo Liang ^a   Chang, Ta Yuan ^b   Chen, Jia ^c   Chang, Catherine C ^b   Zhao, Xiao Nan ^c  

^a SIBS   (China)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

ACAT; ACAT1; Atherosclerosis; Cholesterol; Cholesteryl ester; Dexamethasone; Gene organization; Inhibitor; Interferon ; Macrophage derived foam cell; Regulation of gene expression

Indexed keywords

AVASIMIBE; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; CHOLESTEROL ESTER; COMPLEMENTARY DNA; DEXAMETHASONE; GAMMA INTERFERON; GENE PRODUCT; GENOMIC DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOENZYME; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN ACAT1; STAT1 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CELL DIFFERENTIATION; CLINICAL TRIAL; DNA LIBRARY; DOWN REGULATION; DRUG POTENTIATION; DRUG TARGETING; ENZYME INHIBITION; FOAM CELL; GENE EXPRESSION; GENETIC REGULATION; HUMAN; ISCHEMIC HEART DISEASE; MACROPHAGE; MAMMAL; MONOCYTE; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SCIENTIST; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; UNSPECIFIED SIDE EFFECT; UPREGULATION;

EID: 33646541653     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/14796678.2.1.93     Document Type: Review

References (49)

1. Chang TY, Chang CCY, Cheng D: Acylcoenzyme Acholesterol acyltransferase. Ann. Rev. Biochem. 66, 613-638 (1997).
2. Buhman KF, Accada M, Farese RV Jr: Mammalian acyl-CoA:cholesterol acyltransferases. Biochem. Biophys. Acta 1529, 142-154 (2000).
3. Rudel LL, Lee RG, Cockman TL: Acyl coenzyme A:cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis. Curr. Opin. Lipidol. 12, 121-127 (2001).
4. Chang TY, Chang CCY, Lin S, Yu C, Li BL, Miyazaki A: Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2. Curr. Opin. Lipidol. 12, 289-296 (2001).
5. Smith JL, Rangaraj K, Simpson R et al.: Quantitative analysis of the expression of ACAT genes in human tissues by real-time PCR. J. Lipid Res. 45, 686-696 (2004).
6. Song BL, Wang CH, Yao XM et al.: Human Acyl-CoA:cholesterol, acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma. Biochem. J. (In press) (2005).
7. Ross R. Atherosclerosis - an inflammatory disease. N. Engl J. Med. 340, 115-126 (1999).
8. Glass CK, Witztum. JL: Atherosclerosis: the road ahead. Cell 104, 503-516 (2001).
9. Libby P: Inflammation in atherosclerosis. Nature 420, 868-874 (2002).
10. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH: Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. J. Biol. Chem. 270, 5772-5778 (1995).
11. Tabas I: Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110, 905-911 (2002).
12. Miyazaki A, Sakashita N, Lee O et al.: Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler. Thromb. Vasc. Biol. 18, 1568-1574 (1998).
13. Kusunoki J, Hansoty DK, Aragane K, Fallon JT, Badimon JJ, Fisher EA: Acyl-CoA: cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 103, 2604-2609 (2001).
14. Puglielli L, Konopka G, Pack-Chung E et al.: Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nature Cell Biol. 3, 905-912 (2001).
15. Hutter-Paier B, Huttunen HJ, Puglielli L et al.: The ACAT inhibitors CP-113, 818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44, 227-238 (2004).
16. Chang CCY, Hub HY, Cadigan KM, Chang TY: Molecular cloning and functional expression of human acyl-coenzyme A: cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. 268, 20747-20755 (1993).
17. Li BL, Li XL, Duan ZJ et al.: Human acylcoenzyme A:cholesterol acyltransferase 1 (ACAT1) gene organization and evidence that the 4.3-kilobase ACAT1 mRNA is produced from two different chromosomes. J. Biol. Chem. 274, 11060-11071 (1999).
18. Yang L, Lee O, Chen J: Human acylcoenzyme A:cholesterol acyltransferese 1 sequences (Acat1) located in two different chromosomes (7 and 1) are required to produce a novel ACAT1 isoenzyme with additional sequence at the N terminus. J. Biol Chem. 279, 46253-46262 (2004).
19. Chang CCY, Sakashita N, Ornvold K et al.: Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J. Biol. Chem. 275, 28083-28092 (2000).
20. Sakashita N, Miyazaki A, Takeya M et al.: Localization of human acyl-coenzyme A:cholesterol acyltransferase-1 in macrophages and in various tissues. Am. J. Pathol. 156, 227-236 (2000).
21. Chang CCY, Chen J, Thomas MA et al.: Regulation and immunolocalization of acyl-coenzyme A:cholesterol acyltransferase in mammalian cells as studied with specific antibodies. J. Biol Chem. 270, 29532-29540 (1995).
22. Chang CCY, Lee CYG, Chang ET et al.: Recombinant acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-1) purified to essential homogeneity utilizes cholesterol in mixed micelles or in vesicles in a highly cooperative manner. J. Biol. Chem. 273, 35132-35141 (1998).
23. Lu XH, Lin S, Chang CCY, Chang TY: Mutant acyl-coenzyme A:cholesterol acyltransferase 1 devoid of cysteine residues remains catalytically active. J. Biol. Chem. 277, 711-718 (2002).
24. Zhang Y, YU CJ, Liu J et al.: Cholesterol is superior to 7-ketocholesterol or 7 alpha-hydroxycholesterol as an allosteric activator for acyl-coenzyme A:cholesterol acyltransferase 1. J. Biol. Chem. 278, 11642-11647 (2003).
25. Liu J, Chang CCY, Westover EJ, Covey DF, Chang TY: Investigating the allosterism of Acyl-Coenzyme A: cholesterol acyltransferase (ACAT) by using various sterols: in vitro and intact cell studies. Biochem. J. 1391, 389-397 (2005).
26. Guo ZY, Lin S, Heinen JA, Chang CC, Chang TY: The active site His460 of human acyl-coenzyme A:cholesterot acyltransferase 1 (ACAT1) resides in a hitherto undisclosed transmembrane domain. J. Biol. Chem. 280, 37814-37826 (2005)
27. Gun ZY, Chang CCY, Lu XH, Chen J, Li BL, Chang TY: The disulfide linkage and the free sulfhydryl accessibility of acyl-coenzyme A:cholesterol acyltransferase 1 as studied by using mPEG5000-maleimide. Biochemistry 44, 6537-6546 (2005).
28. Hofmann K A superfamily of membrane-bound O-acyltransferases with implications for Wnt signaling. Trends Biochem. Sci. 25, 111-112 (2000).
29. Lin S, Lu XH, Chang CCY, Chang TY: Human acyl-coenzyme A:cholesterol acyltransferase expressed in Chinese hamster ovary cells: membrane topology and active site location. Mol. Biol. Cell. 14, 2447-2460 (2003).
30. Yu CJ, Chen J, Lin S et al.: Human acylcoenzyme A:cholesterol acyltransferase-1 is a homotetrameric enzyme in intact cells and in vitro. J. Biol Chem. 274, 36139-36145 (1999).
31. Yu CJ, Zhang Y, Lu XH, Chang CCY, Chang TY: Role of the N-terminal hydrophilic domain of acyl-coenzyme A:cholesterol acyltransferase 1 on the enzyme's quaternary structure and catalytic efficiency. Biochemistry 41, 3762-3769(2002).
32. Lu XH, Lin S, Chang CCY, Chang TY: Mutant acyl-coenzyme A:cholesterol acyltransferase 1 devoid of cysteine residues remains catalytically active. J. Biol. Chem. 277, 711-718 (2002)
33. Horton JD, Goldstein JL, Brown MS: SREBPs: transcriptional mediators of lipid homeostasis. Cold Spring Harb. Symp. Quant. Biol. 67, 491-498 (2002).
34. Wang HX, Germain SJ, Benfield PP, Gillies PJ: Gene expression of acylcocnzyme-A: cholesterol-acyltransferase is upregulated in human monocytes during differentiation and foam cell formation. Arterioscler. Thromb. Vasc. Biol. 16, 809-814 (1996).
35. Miyazaki A, Sakashita N, Lee O et al.: Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler. Thromb. Vasc. Biol. 18, 1568-1574 (1998).
36. Panousis CG, Zuckerman SH: Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-gamma. J. Lipid. Res. 41, 75-83 (2000).
37. Yang JB, Duan ZJ, Yao W et al.: Synergistic transcriptional activation of human ACAT 1 gene by IFN-gamma and ATRA in THP-1. J. Biol. Chem. 276, 20989-20998 (2001).
38. Nagy L, Tontonoz P, Alvarez JG et al.: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93., 229-240 (1998).
39. Cheng W, Kvilekval KV, Abumrad NA: Dexamethasone enhances accumulation of cholesteryl esters by human macrophages. Am. J. Physiol. 269, 642-648 (1995).
40. Yang L, Yang JB, Chen J et al.: Enhancement of human ACAT1 gene expression to promote the macrophage derived foam cell formation by dexamethasone. Cell Res. 14, 315-323 (2004).
41. Hori M, Miyazaki A, Tamagawa H et al.: Upregulation of acyl-coenzyme A:cholesterol acyltransferase-1 by transforming growth factor-betal during differentiation of human monocytes into macrophages. Biochem. Biophys. Res. Commun. 320, 501-505 (2004).
42. Furukawa X, Hori M, Ouchi N et al.: Adiponectin downregulates acyl-coenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 317, 831-836 (2004).
43. Chinetti G, Lestavel S, Fruchart JC, Clavey V, Staels B: Peroxisome proliferator-activated receptor reduces cholesterol esterification in macrophages. Circ. Res. 92, 212-217 (2003).
44. Yang L, Chen J, Chang CCY et al.: A stable stem-loop structure enhances selection of the first 5′-ORF-AUG as a main start codon for translation initiation of human ACAT1 mRNA. Acta Biochem. Biophys. Sin. 36, 259-268 (2004).
45. Bocan TM, Mueller SB, Uhlendorf PD, Newton RS, Krause BR: Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for and-atherosderotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation. Arterioscler Thromb. 11, 1830-1843 (1991).
46. Fazio S, Major AS, Swift LL et al.: Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J. Clin. Invest. 107, 163-171 (2001).
47. Bocan TM, Krause BR, Rosebury WS et al.: The combined effect of inhibiting both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression. Atherosclerosis 157, 97-105 (2001).
48. Sahi J, Milad MA, Zheng X et al.: Avasimibe induces CYP3A4 and multiple drug resistance protein 1 gene expression through activation of the pregnane X receptor. J. Pharmacol. Exp. Ther. 306, 1027-1034 (2003).
49. Tardif JC, Gregoire J, L'Allier Pl, et al.: Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 110, 3372-3377 (2004).